Researchers performed a systematic review of PubMed literature until May
2020 including clinical sequencing studies that utilized next-generation sequencing (NGS) in individuals with epilepsy, autism spectrum disorder (ASD), or intellectual disability (ID).
The study authors evaluated whether psychosis transition can be predicted in patients with clinical high-risk or recent-onset depression using multimodal machine learning that integrates clinical and neurocognitive data, structural magnetic resonance imaging, and polygenic risk scores for schizophrenia.
Cognitive behavioral therapy is the first line treatment for insomnia, but studies have reported potential negative effects. This review aims to understand the extent to which adverse events are monitored for and reported in trial literature.
This clinical review assessed the use of exposure and response prevention therapy for patients with obsessive-compulsive disorder during the COVID-19 pandemic.
Cannabidiol (CBD) may be a safe and effective treatment option for cannabis use disorder.
The 10-item progress assessment tool represents a pragmatic approach to ongoing monitoring in substance use disorders.